Sandy works with research sites, sponsors, and patient advocacy groups in support of WCG’s mission to accelerate the development of new medical therapies by improving the conduct and quality of clinical trials.  She provides consultation to research sites by strategically aligning clinical solutions to improve and create efficient processes in the areas of ethical review, biosafety, trial initiation, research financial services, staffing augmentation, and support for investigator-initiated trials with DSMBs, clinical endpoints, and statistical consulting.  Prior to joining WCG, Sandy was Vice-President of US Oncology Research, an oncology site management organization of independent practices and hospital research programs with approximately 1,000 investigators and 175 research sites.